|
SENP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.501600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.702440E-01 |
| Normal-vs-Stage2 |
5.002600E-01 |
| Normal-vs-Stage3 |
1.999610E-01 |
| Normal-vs-Stage4 |
6.842600E-01 |
| Stage1-vs-Stage2 |
8.739400E-01 |
| Stage1-vs-Stage3 |
3.149600E-02 |
| Stage1-vs-Stage4 |
4.424200E-01 |
| Stage2-vs-Stage3 |
1.321970E-01 |
| Stage2-vs-Stage4 |
5.078400E-01 |
| Stage3-vs-Stage4 |
8.485000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.194400E-01 |
| Normal-vs-AfricanAmerican |
6.794200E-01 |
| Normal-vs-Asian |
7.247000E-01 |
| Caucasian-vs-AfricanAmerican |
2.943800E-01 |
| Caucasian-vs-Asian |
9.807800E-01 |
| AfricanAmerican-vs-Asian |
7.335200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.697780E-01 |
| Normal-vs-Female |
7.011900E-02 |
| Male-vs-Female |
3.542500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.302600E-01 |
| Normal-vs-Extreme_Weight |
3.950400E-02 |
| Normal-vs-Obese |
3.355800E-01 |
| Normal-vs-Extreme_Obese |
1.595600E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.176200E-01 |
| Normal_Weight-vs-Obese |
7.215700E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.038000E-01 |
| Extreme_Weight-vs-Obese |
1.394310E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.353200E-01 |
| Obese-vs-Extreme_Obese |
8.082500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.927700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.226600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.674200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.561700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.927500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.440000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.215800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.981200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.228000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.709800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.252000E-01 |
| Normal-VS-Type2 PRCC |
1.824220E-02 |
| Normal-VS-KIRP CIMP |
3.862300E-02 |
| Normal-VS-Unclassified PRCC |
2.252000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.397800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.878200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.274450E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.252240E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.749540E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.185230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.283600E-02 |
| Normal-vs-N1 |
3.454100E-02 |
| Normal-vs-N2 |
5.076100E-02 |
| N0-vs-N1 |
4.196200E-03 |
| N0-vs-N2 |
3.439900E-02 |
| N1-vs-N2 |
8.027200E-01 |
|
|
